GUSTAFSON MARK
CIK: 0001303996
Associated companies
Transaction History
| ALZN | ▼ Sell | Open Market | 20,000 | $24K | 3/31/2022 | View on chart |
| ALZN | ▲ Buy | Option Exercise | 50,000 | $0 | 3/15/2022 | View on chart |
| ALZN | ▼ Sell | Open Market | 20,000 | $57K | 12/14/2021 | View on chart |
| ALZN | ▲ Buy | Option Exercise | 47,222 | $0 | 10/15/2021 | View on chart |
| ALZN | ▲ Buy | Option Exercise | 2,778 | $0 | 9/13/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Alzamend Neuro (ALZN) Receives Analyst Upgrade
Alzamend Neuro received an upgrade to a buy rating from an analyst. This move aligns with the firm's price target of $26.00, which is significantly higher than the stock's 52-week range of $0.84 to $2.68. The upgrade provides a positive signal for the company's outlook, although the stock currently trades near its support level.
Alzamend Neuro (ALZN) Receives Analyst Upgrade. Alzamend Neuro received an upgrade to a buy rating from an analyst. This move aligns with the firm's price target of $26.00, which is significantly higher than the stock's 52-week range of $0.84 to $2.68. The upgrade provides a positive signal for the company's outlook, although the stock currently trades near its support level.